Ohr Pharmaceutical Regains Compliance with NASDAQ Listing Requirements
21 Febrero 2019 - 9:45AM
Ohr Pharmaceutical, Inc. (Nasdaq: OHRP) today announced that it
received notice from The Nasdaq Stock Market LLC indicating that
the Company has regained compliance with the minimum bid price
requirement under NASDAQ Listing Rule 5550(a)(2) (the "Bid Price
Rule") for continued listing on The NASDAQ Capital Market.
Accordingly, the Company has regained compliance with the Bid Price
Rule and NASDAQ considers the matter closed.
Ohr Pharmaceutical Contact: Investor
Relations
OP: 212-682-8452ir@ohrpharmaceutical.com
Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)
Gráfica de Acción Histórica
De Ago 2024 a Sep 2024
Ohr Pharmaceuticals, Inc. (NASDAQ:OHRP)
Gráfica de Acción Histórica
De Sep 2023 a Sep 2024
Real-Time news about Ohr Pharmaceuticals, Inc. (NASDAQ): 0 recent articles
Más de Artículos de Noticias